Of the 148 live donors, 24 were hypertensive (ABPM > 135/85 mmHg and clinic BP > 140/90 mmHg) before donation. The group concluded that patients with moderate, essential hypertension and normal kidney function have no adverse outcomes with respect selleck screening library to BP, renal function or urinary protein excretion in the first year after living kidney donation. Young et al. performed a systematic review and meta-analysis and identified six studies

on 125 hypertensive donors (Fig. 2).30 A number of methodological issues restrict the external validity of all of these studies. Follow up was for a median of 2.6 years, with two having a mean follow up of over 5 years. One study described a 14 µmol/L greater rise in serum creatinine in hypertensive donors compared with donors who were normotensive pre-donation. Two studies described conflicting results on the change in renal function using radioisotope or inulin GFR between 62 hypertensive donors and 527 normotensive donors. One study demonstrated that BP in hypertensive donors at 1 year decreased by 5 mmHg systolic and 6 mmHg diastolic compared with normotensive donors. An additional study found that mean arterial BP following donation decreased

more often in hypertensive donors. Please refer to Table 1– Characteristics of included studies (Appendices). There is a lack of prospective controlled long-term data regarding the effects of nephrectomy in both normal and hypertensive donors. More precise information Aurora Kinase is required and this would ideally be collected prospectively using a live donor registry. On the basis of limited studies, nephrectomy appears to lead to a small increase in BP but there is no evidence of an increased risk HER2 inhibitor of developing hypertension. However, to better assess whether there is an alteration in the risk of developing hypertension, it is acknowledged that prospective

studies of age- and sex-matched individuals with and without nephrectomy would need to be performed. The recommendation to exclude from donation individuals with poorly controlled hypertension or with known hypertensive end-organ damage (e.g. retinopathy, left ventricular hypertrophy, stroke, proteinuria and renal impairment) is based on the known natural history of these disorders. No study has been performed comparing the outcome in these subjects who donate, compared with those who do not. British Transplant Society/British Renal Association: An extensive, 100-page document has been produced outlining similar issues to those discussed here.31 The full version of these British Live Donor Guidelines is available at: http://www.bts.org.uk/transplantation/standards-and-guidelines/ Prospective donors should not be precluded from further evaluation if their office (casual) BP recordings are below 140/90 mmHg. The Amsterdam Forum: A short manuscript outlining similar issues to those discussed here.32 Hypertension has been considered to be a contraindication in potential renal transplant donors.